Cargando…
Elimination of Intravenous Di-2-Ethylhexyl Phthalate Exposure Abrogates Most Neonatal Hypertension in Premature Infants with Bronchopulmonary Dysplasia
(1) Background: The incidence of hypertension in very low birthweight (VLBW) infants in a single neonatal intensive care unit (NICU) dropped markedly during a 2-year period when the IV fluid (IVF) in both the antenatal unit and the NICU temporarily changed to a di-2-ethylhexyl phthalate (DEHP)-free...
Autores principales: | Jenkins, Randall, Farnbach, Katia, Iragorri, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067010/ https://www.ncbi.nlm.nih.gov/pubmed/33918157 http://dx.doi.org/10.3390/toxics9040075 |
Ejemplares similares
-
Di-(2-ethylhexyl) phthalate and autism spectrum disorders
por: Testa, Chiara, et al.
Publicado: (2012) -
Toxic Effects of Di-2-ethylhexyl Phthalate: An Overview
por: Rowdhwal, Sai Sandeep Singh, et al.
Publicado: (2018) -
Risk assessment of di(2-ethylhexyl) phthalate in the workplace
por: Kim, Hyeon-Yeong
Publicado: (2016) -
The Impact of Di-2-Ethylhexyl Phthalate on Sperm Fertility
por: Khasin, Liliya Gabelev, et al.
Publicado: (2020) -
Teratogenicity of di(2-ethylhexyl) phthalate (DEHP) and di-n-butyl phthalate (DBP) in mice.
por: Shiota, K, et al.
Publicado: (1982)